How to Document Botox and Dermal Filler Treatments

At a Glance

• Botox and dermal filler treatments require thorough documentation for patient safety and compliance.
• Key documentation includes product information, lot numbers, treatment sites, consent, and follow-up.
• This article focuses exclusively on documentation categories — it does not provide injection maps, doses, techniques, or treatment instructions.
• Proper documentation supports recall response, adverse event management, and continuity of care.

Direct Answer

Documenting Botox and dermal filler treatments involves recording product information, lot numbers, treatment sites, provider identity, consent, photos, and follow-up. This article focuses exclusively on documentation categories — it does not provide injection maps, doses, techniques, or treatment instructions. Proper documentation supports patient safety, recall response, and compliance.

Patient Information

Document:

• Patient identity (name, date of birth, chart number)
• Date and time of treatment
• Treating provider name and credentials
• Delegating or supervising provider (if applicable)

Pre-Treatment Assessment

Document:

• Medical history reviewed and updated
• Current medications and supplements
• Allergies and prior adverse reactions
• Pregnancy and breastfeeding status
• Treatment-area assessment
• Contraindications identified
• Patient goals and expectations discussed

Good Faith Exam

If a Good Faith Exam is required:

• Date and time of the exam
• Provider who performed the exam
• Exam findings
• Treatment decision
• Whether in-person or telehealth (if permitted)

See What Is a Good Faith Exam in Medical Aesthetics?.

Consent

Document:

• Signed informed consent specific to the treatment (Botox or filler)
• Consent includes risks, benefits, alternatives, and expected outcomes
• Consent for before-and-after photography
• Date of consent

Product Information

For each product used, document:

• Product name (brand and generic)
• Manufacturer
• Product concentration or strength
• Volume or units used
• Expiration date verified before use
• Whether the product is compounded (if applicable)

Lot Numbers

Document:

• The lot number for every product used
• This is critical for recall response and patient safety
• A lot-tracking log should be maintained separately

See Aesthetic Treatment Documentation Checklist for the full documentation framework.

Treatment Sites

Document:

• Anatomical areas treated (e.g., glabella, nasolabial folds, lips)
• Specific injection or treatment sites
• Units or volume per site
• Anatomical diagram or facial map where useful
• Symmetry notes or asymmetry corrections

Note: This article covers documentation categories only. It does not provide injection maps, doses, or techniques.

Patient Tolerance

Document:

• Patient tolerance during the treatment
• Any immediate reactions or observations
• Pain management used (topical anesthetic, ice, etc.)
• Immediate post-treatment appearance

Deviations

Document:

• Any deviations from the standard protocol
• Reason for the deviation
• Clinical justification

Photos

Document:

• Standardized before photos with consistent lighting and angles
• Immediate post-treatment photos (if applicable)
• Photos labeled with patient ID, date, and treatment area
• Photo consent documented
• Photos stored securely

Post-Treatment Instructions

Document:

• Post-treatment instructions provided to the patient
• What to watch for (swelling, bruising, signs of complication)
• When to contact the practice
• When to seek emergency care
• Written instructions given

Follow-Up

Document:

• Scheduled follow-up date
• Follow-up method (in-person, phone, message)
• Patient-reported outcomes at follow-up
• Provider assessment at follow-up
• Plan for next treatment or maintenance

Adverse Events

If an adverse event occurs:

• Date, time, and description of the event
• Product and lot number involved
• Treatment site
• Patient symptoms and severity
• Intervention taken
• Patient outcome
• Reporting to FDA MedWatch or manufacturer (if applicable)
• Follow-up plan

See Common Medical Spa Documentation Mistakes for pitfalls to avoid.

What Providers Should Verify

• That product name, lot number, and volume/units are documented for every treatment
• That treatment sites are recorded with anatomical specificity
• That consent is obtained and documented before each treatment
• That post-treatment instructions are provided and documented
• That adverse events are documented and reported as required
• That documentation meets your state's recordkeeping requirements

Frequently Asked Questions

Should product lot numbers be documented for Botox and fillers? Yes. Lot numbers should be recorded for every product used in every treatment. Lot tracking is critical for recall response and patient safety follow-up.

How should treatment sites be documented? Treatment sites should be documented with anatomical specificity — the area treated, specific injection or treatment sites, and units or volume per site. An anatomical diagram or facial map can be useful.

What should be documented after an adverse event? Document the date, time, description, product and lot number, treatment site, patient symptoms, intervention, outcome, reporting (if applicable), and follow-up plan.

How should follow-up be documented? Document the scheduled follow-up date, method, patient-reported outcomes, provider assessment, and plan for next treatment or maintenance.